Related Experiment Video
Updated: Aug 14, 2026
09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
Beyond PEG: Emerging Polymer Lipid Alternatives for Lipid Nanoparticle (LNP) Formulations
Zihnil A I Mazrad1,2, Yi Ju3, Stephen J Kent4,5
1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|August 12, 2026
Summary
Poly(ethylene glycol)-lipids (PEG-lipids) enable nucleic acid delivery but cause immune issues. New PEG-alternative lipid nanoparticle designs offer improved strategies for repeated dosing and next-generation therapeutics.
Area of Science:
- Biotechnology
- Nanomedicine
- Drug Delivery
Background:
- Lipid nanoparticles (LNPs) are leading platforms for nucleic acid therapeutics like siRNA and mRNA.
- Poly(ethylene glycol)-lipids (PEG-lipids) are crucial for LNP stability and function but cause immunological limitations.
- Limitations of PEGylation include complement activation, anti-PEG antibodies, and accelerated blood clearance, hindering repeated dosing.
Purpose of the Study:
- To review recent advances in designing PEG-alternative LNP surface coatings.
- To compare the impact of different polymer chemistries and architectures on LNP properties and biological outcomes.
- To discuss challenges and future directions for developing next-generation stealth LNPs.
Main Methods:
- Review of recent literature on PEG-alternative LNP designs.
- Comparison of non-PEG polymers, zwitterionic lipids, polypeptides, and modified PEG analogues.
- Analysis of how surface chemistry influences LNP formation, physicochemical properties, biodistribution, cellular uptake, and immunogenicity.
Main Results:
- Various PEG-alternative materials (non-PEG polymers, zwitterionic lipids, polypeptides) are emerging for LNP surface engineering.
- Polymer chemistry, anchor geometry, and grafting architecture significantly impact LNP characteristics and biological interactions.
- These alternatives offer potential to overcome PEGylation-associated limitations, enabling improved LNP behavior.
Conclusions:
- PEG-alternative lipids represent distinct materials, not mere PEG mimics, creating novel nano-bio interfaces.
- Further research is needed to understand in vivo behavior and rationally design next-generation stealth LNPs.
- These advancements are critical for enabling repeated and long-term dosing strategies for nucleic acid therapeutics.
